Jahangir Sharifi, MD
Jahangir Sharifi, MD is the owner and practicing Otolaryngologist at L.A. Sinus & Allergy Specialists, located in Los Angeles, CA. Dr. Sharifi graduated with his undergraduate degree from Dartmouth College in Engineering Sciences, and his M.D. from Keck School of Medicine of USC. He is board certified in Otolaryngology from the American Board of Otolaryngology, and he currently serves as the Section Chief of Otolaryngology/Head and Neck Surgery at White Memorial Medical Center.
L.A. Sinus and Allergy Specialists, Los Angeles, CA, 2008 – present Started a single specialty private practice covering the White Memorial Medical Center, and Glendale Adventist Medical Center, and Pacific alliance Medical Center as attending medical staff for the Department of Otolaryngology, Head and Neck Surgery, since June 2008.Currently the Section Chief for the Division of Otolaryngology at White Memorial Medical Center.
Affiliated ENT Specialists, Los Angeles, CA, 2006 – 2008 In private practice at the White Memorial Medical Center, Los Angeles, CA and Glendale Adventist Medical Center, Glendale, CA as attending medical staff for the Department of Otolaryngology, Head and Neck Surgery, since September 2006.
Los Angeles County Medical Center / University of Southern California, Los Angeles, CA 2002 - 2006 Department of Otolaryngology, Head and Neck Surgery. Completed post-graduate residency training in June 2006.
Los Angeles County Medical Center / University of Southern California, Los Angeles, CA 2001-2002 Department of Surgery, August 23, 2001 – June 30, 2002, completed one year of General Surgery Internship.
University of Southern California, Los Angeles, CA 1993- 2001 Keck School of Medicine, MD/PhD program. MD degree granted in May 11, 2001. Four years of graduate coursework and basic science research in the Department of Pathology.
Dartmouth College, Hanover, NH 1988-1992 Bachelor's Degree, double major in Engineering Sciences and Biochemistry, cum Laude.
American Academy of Otolaryngology – Head and Neck Surgery
American Academy of Otolaryngic Allergy
1999 Outstanding Pathology Graduate Student of the Year Award, Keck School of Medicine, Department of Pathology
1998 USC Graduate and Professional Outstanding Student Leadership Recognition Award
1998 American Institute for Cancer research student travel scholarship for Annual Meeting
1994, 1996, 1997, 1998, 1999 USC Medical Student Summer Research Fellowship
1989-92 Thomas Wilson endowed scholar at Dartmouth College for engineering students displaying academic and personal excellence
1988-89 Dartmouth College Honor list
1991 UC San Diego Provost's Honor List (college exchange program)
2005 American College of Surgeons, Southern California Chapter, Santa Barbara, CA Intraoperative Intact Parathyroid Hormone Testing During Parathyroidectomy – USC Experience, Sharifi J, Maceri, D
2000 Society of Nuclear Medicine Annual Meeting, St. Louis, MO Engineered chTNT-3 derivatives for the radioimmunoscintigraphy of solid tumors, Biela BH, Sharifi J, Khawli LA, Hu P, Bai WG, Epstein AL
1999 American Association for Cancer Research Annual Meeting, Philadelphia, PA Construction and characterization of procoagulant fusion molecules for the thrombogenic treatment of solid tumors, Sharifi J, Bai WG, Hornick JL, Khawli LA, Thorpe PE, Epstein AL
1998 American Association for Cancer Research Annual Meeting, New Orleans, LA A chimeric Lym-1/Interferon- antibody fusion protein targets and inhibits the growth of Raji human Burkitt's lymphoma cells, Sharifi J, Hornick JL, Khawli LA, Hu P, Yun A, Epstein AL
Maceri DR, Kokot N, Green K, Montgomery V, Sharifi J. Split central venous sampling of parathyroid hormone: an adjunct to surgical exploration. Head Neck 33(12):1715-8, (2011).
Hu P. Yan J. Sharifi J. Bai T. Khawli LA. Epstein AL. Comparison of three different targeted tissue factor fusion proteins for inducing tumor vessel thrombosis. Cancer Research. 63:5046, (2003).
Sharifi J. Khawli LA. Hu P. Li J. Epstein AL. Generation of human interferon gamma and tumor Necrosis factor alpha chimeric TNT-3 fusion proteins. Hybrid Hybridomics. 21:421, (2002).
Khawli LA. Mizokami MM. Sharifi J. Hu P. Epstein AL. Pharmacokinetic characteristics and biodistribution of radioiodinated chimeric TNT-1, -2, and -3 monoclonal antibodies after chemical modification with biotin. Cancer Biotherapy &; Radiopharmaceuticals. 17:359, (2002)
Sharifi J. Khawli LA. Hu P. King S. Epstein AL. Characterization of a phage display-derived human monoclonal antibody (NHS76) counterpart to chimeric TNT-1 directed against necrotic regions of solid tumors. Hybrid Hybridomics. 20:305, (2001).
Hornick JL, Sharifi J, Khawli LA, Hu P, Bai WG, Alauddin MM. Mizokami MM., and Epstein AL, Single amino acid substitution in the Fc region of chimeric TNT-3 antibody accelerates clearance and improves immunoscintigraphy of solid tumors, Journal of Nuclear Medicine, 41:355, (2000).
Sharifi J, Khawli LA, Hornick JL, Epstein AL, Improving monoclonal antibody pharmacokinetics via chemical modification, Quarterly J. Nuclear Med, 42:242 (1998).
Hornick JL, Sharifi J, Khawli LA, Hu P, Biela BH, Mizokami MM, Yun A, Taylor CR, and Epstein AL, A New Chemically Modified Chimeric TNT-3 Monoclonal Antibody Directed Against DNA for the Radioimmunotherapy of Solid Tumors. Cancer Biotherapy &; Radiopharmaceuticals, 13:255 (1998).
Hornick JL, Khawli LA, HU,P, Biela BH, Sharifi J, and Epstein AL, Pretreatment with a Monoclonal Antibody/Interleukin-2 Fusion Protein Directed against DNA Enhances the Delivery of Therapeutic Molecules to Solid Tumors. Clinical Cancer Research 5:51 (1999).
Khawli LA, Hornick JL, Sharifi J, Epstein AL, Improving the chemotherapeutic index of Iudr using a vasoactive immunoconjugate. Radiochimica Acta, 72:83 (1997).
Khawli LA, Milkie MN, Hornick JL, Glasky MS, Sharifi J, Hu P, Epstein AL, Production of F(ab’)2 fragments in high yield from IgG1 monoclonal antibodies. Int. J. Biochromat., 2:89 (1996)
Sharifi J, St.Germain D, The cDNA for the Type I Iodothyronine 5'-Deiodinase Encodes an Enzyme with Both High and Low Km Activity. JBC, 267:12539 (1992).